Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Current Debt (2010 - 2026)

Updated

Brainstorm Cell Therapeutics (BCLI) recorded Current Debt of -$41,000 in Q4 2010.

Analysis

Brainstorm Cell Therapeutics (BCLI) Current Debt (2010 - 2026) Analysis & Trends

For FY2010, Brainstorm Cell Therapeutics reported Current Debt of -$46,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn - -125,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -125,000.00
Mar 31, 2026 280,000.00
Dec 31, 2025 781,000.00
Jun 30, 2025 -1.10 Mn
Mar 31, 2025 900,000.00
Dec 31, 2010 -41,000.00
Sep 30, 2010 40,000.00
API Access

Brainstorm Cell Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BCLI&period=max&api_key=YOUR_API_KEY